Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants

Best Practice and Research: Clinical Gastroenterology

Volumn 31, Issue 3, 2017, Pages 249-255

  Lin, Chih Lin ^a,b   Kao, Jia Horng ^c,d  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL CHENGCHI UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Chronic hepatitis B; Cirrhosis; Genotype; HBV mutant; Hepatitis B virus (HBV); Hepatocellular carcinoma

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN;

ACUTE HEPATITIS B; CHRONIC HEPATITIS B; CHRONICITY; CLINICAL PRACTICE; DRUG TREATMENT FAILURE; GENETIC MARKER; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HEPATITIS B VIRUS; HEPATITIS B VIRUS GENOTYPE A; HEPATITIS B VIRUS GENOTYPE B; HEPATITIS B VIRUS GENOTYPE C; HEPATITIS B VIRUS GENOTYPE D; HUMAN; LIVER CELL CARCINOMA; MOLECULAR EPIDEMIOLOGY; PATHOGENESIS; REVIEW; SEROCONVERSION; VIRUS MUTANT; DISEASE EXACERBATION; GENOTYPE; HEPATITIS B; LIVER TUMOR; MUTATION; PATHOGENICITY; RISK FACTOR; VIROLOGY;

DISEASE PROGRESSION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MUTATION; RISK FACTORS;

EID: 85019411425     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2017.04.010     Document Type: Review

References (101)

1. Kao, J.H., Chen, D.S., Global control of hepatitis B virus infection. Lancet Infect Dis 2 (2002), 395–403.
2. Beasley, R.P., Rocks along the road to the control of HBV and HCC. Ann Epidemiol 19 (2009), 231–234.
3. Lau, J.Y., Wright, T.L., Molecular virology and pathogenesis of hepatitis B. Lancet 342 (1993), 1335–1340.
4. Urban, S., Schulze, A., Dandri, M., Petersen, J., The replication cycle of hepatitis B virus. J Hepatol 52 (2010), 282–284.
5. Hunt, C.M., McGill, J.M., Allen, M.I., Condreay, L.D., Clinical relevance of hepatitis B viral mutations. Hepatology 31 (2000), 1037–1044.
6. Kao, J.H., Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J Gastroenterol Hepatol 17 (2002), 643–650.
7. Kao, J.H., Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan. Intervirology 46 (2003), 400–407.
8. Lin, C.L., Kao, J.H., The clinical implications of hepatitis B virus genotype: recent advances. J Gastroenterol Hepatol 26:Suppl 1 (2011), 123–130.
9. Lin, C.L., Kao, J.H., Hepatitis B viral factors and treatment responses in chronic hepatitis B. J Formos Med Assoc 112 (2013), 302–311.
10. Lin, C.L., Kao, J.H., HBV genotypes and variants. Cold Spring Harb Perspect Med, 5, 2015, a021436.
11. Chotiyaputta, W., Lok, A.S., Hepatitis B virus variants. Nat Rev Gastroenterol Hepatol 6 (2009), 453–462.
12. Kao, J.H., Chen, P.J., Chen, D.S., Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects. Adv Cancer Res 108 (2010), 21–72.
13. Ngui, S.L., Teo, C.G., Hepatitis B virus genomic heterogeneity: variation between quasispecies may confound molecular epidemiological analyses of transmission incidents. J Viral Hepat 4 (1997), 309–315.
14. Locarnini, S., Littlejohn, M., Aziz, M.N., Yuen, L., Possible origins and evolution of the hepatitis B virus (HBV). Semin Cancer Biol 23 (2013), 561–575.
15. Chen, B.F., Chen, P.J., Jow, G.M., Liu, C.J., Kao, J.H., Chen, D.S., High prevalence of mixed genotype infections in hepatitis B virus infected intravenous drug users. J Med Virol 74 (2004), 536–542.
16. Lin, C.L., Liu, C.J., Chen, P.J., Lai, M.Y., Chen, D.S., Kao, J.H., High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users. J Med Virol 79 (2007), 1674–1678.
17. Yang, J., Xing, K., Deng, R., Wang, J., Wang, X., Identification of hepatitis B virus putative intergenotype recombinants by using fragment typing. J Gen Virol 87 (2006), 2203–2215.
18. Sugauchi, F., Orito, E., Ichida, T., Kato, H., Sakugawa, H., Kakumu, S., et al. Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene. J Virol 76 (2002), 5985–5992.
19. Wang, Z., Liu, Z., Zeng, G., Wen, S., Qi, Y., Ma, S., et al. A new intertype recombinant between genotypes C and D of hepatitis B virus identified in China. J Gen Virol 86 (2005), 985–990.
20. Zhou, B., Xiao, L., Wang, Z., Chang, E.T., Chen, J., Hou, J., Geographical and ethnic distribution of the HBV C/D recombinant on the Qinghai-Tibet Plateau. PLoS One, 6, 2011, e18708.
21. Shen, L., Yin, W., Zheng, H., Cui, F., Zhang, S., Wang, F., et al. Molecular epidemiological study of hepatitis B virus genotypes in Southwest, China. J Med Virol 86 (2014), 1307–1313.
22. Tran, T.T., Trinh, T.N., Abe, K., New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol 82 (2008), 5657–5663.
23. Phung, T.B., Alestig, E., Nguyen, T.L., Hannoun, C., Lindh, M., Genotype X/C recombinant (putative genotype I) of hepatitis B virus is rare in Hanoi, Vietnam-genotypes B4 and C1 predominate. J Med Virol 82 (2010), 1327–1333.
24. Hou, J., Liu, Z., Gu, F., Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci 2 (2005), 50–57.
25. Lin, C.L., Kao, J.H., Chen, B.F., Chen, P.J., Lai, M.Y., Chen, D.S., Application of hepatitis B virus genotyping and phylogenetic analysis in intrafamilial transmission of hepatitis B virus. Clin Infect Dis 41 (2005), 1576–1581.
26. Matsuura, K., Tanaka, Y., Hige, S., Yamada, G., Murawaki, Y., Komatsu, M., et al. Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A. J Clin Microbiol 47 (2009), 1476–1483.
27. Lin, C.L., Kao, J.H., Clinical implications of hepatitis B virus variants. J Formos Med Assoc 109 (2010), 321–325.
28. Lin, C.L., Kao, J.H., Hepatitis B viral factors and clinical outcomes of chronic hepatitis B. J Biomed Sci 15 (2008), 137–145.
29. Mansourian, P.G., Ghany, M.G., Thomas, E., Spontaneous mutations in the HBV genome and their clinical implications. Curr Hepat Rep 12 (2013), 79–87.
30. Sugiyama, M., Tanaka, Y., Kato, T., Orito, E., Ito, K., Acharya, S.K., et al. Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology 44 (2006), 915–924.
31. Liu, C.J., Cheng, H.R., Chen, C.L., Chen, T.C., Tseng, T.C., Wang, Z.L., et al. Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: genotype B vs C. J Viral Hepat, 18, 2011 e482–90.
32. Liu, C.J., Jeng, Y.M., Chen, C.L., Cheng, H.R., Chen, P.J., Chen, T.C., et al. Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B. J Infect Dis 199 (2009), 742–749.
33. Kao, J.H., Chen, P.J., Lai, M.Y., Chen, D.S., Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 124 (2003), 327–334.
34. Sharma, S., Sharma, B., Singla, B., Chawla, Y.K., Chakraborti, A., Saini, N., et al. Clinical significance of genotypes and precore/basal core promoter mutations in HBV related chronic liver disease patients in North India. Dig Dis Sci 55 (2010), 794–802.
35. Ni, Y.H., Chang, M.H., Wu, J.F., Hsu, H.Y., Chen, H.L., Chen, D.S., Minimization of hepatitis B infection by a 25-year universal vaccination program. J Hepatol 57 (2012), 730–735.
36. Lin, C.L., Kao, J.H., Perspectives and control of hepatitis B virus infection in Taiwan. J Formos Med Assoc 114 (2015), 901–909.
37. Mendy, M., D'Mello, F., Kanellos, T., Oliver, S., Whittle, H., Howard, C.R., Envelope protein variability among HBV-Infected asymptomatic carriers and immunized children with breakthrough infections. J Med Virol 80 (2008), 1537–1546.
38. Chang, M.H., Breakthrough HBV infection in vaccinated children in Taiwan: surveillance for HBV mutants. Antivir Ther 15 (2010), 463–469.
39. Lai, M.W., Lin, T.Y., Tsao, K.C., Huang, C.G., Hsiao, M.J., Liang, K.H., et al. Increased seroprevalence of HBV DNA with mutations in the S gene among individuals greater than 18 years old after complete vaccination. Gastroenterology 143 (2012), 400–407.
40. Huang, Y.W., Lin, C.L., Chen, P.J., Lai, M.Y., Kao, J.H., Chen, D.S., Hepatitis B viral genotype in Taiwanese patients with acute hepatitis B. Hepatogastroenterology 55 (2008), 633–635.
41. Kao, J.H., Chen, P.J., Lai, M.Y., Chen, D.S., Clinical and virological aspects of blood donors infected with hepatitis B virus genotypes B and C. J Clin Microbiol 40 (2002), 22–25.
42. Kao, J.H., Chen, P.J., Lai, M.Y., Chen, D.S., Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 118 (2000), 554–559.
43. Yotsuyanagi, H., Okuse, C., Yasuda, K., Orito, E., Nishiguchi, S., Toyoda, J., et al., Japanese Acute Hepatitis B Group. Distinct geographic distributions of hepatitis B virus genotypes in patients with acute infection in Japan. J Med Virol 77 (2005), 39–46.
44. Inoue, J., Kondo, Y., Umetsu, T., Yamamoto, T., Miura, M., Mano, Y., et al. Shifting hepatitis B virus genotypes of acute hepatitis B patients in northeast Japan. J Med Virol 88 (2016), 69–78.
45. Ito, K., Yotsuyanagi, H., Yatsuhashi, H., Karino, Y., Takikawa, Y., Saito, T., et al., Japanese AHB Study Group. Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults. Hepatology 59 (2014), 89–97.
46. Sarkar, N., Pal, A., Das, D., Saha, D., Biswas, A., Bandopadhayay, B., et al. Virological characteristics of acute hepatitis B in Eastern India: critical differences with chronic infection. PLoS One, 10, 2015, e0141741.
47. Pezzano, S.C., Torres, C., Fainboim, H.A., Bouzas, M.B., Schroder, T., Giuliano, S.F., et al. Hepatitis B virus in Buenos Aires, Argentina: genotypes, virological characteristics and clinical outcomes. Clin Microbiol Infect 17 (2011), 223–231.
48. Chen, B.F., Liu, C.J., Jow, G.M., Chen, P.J., Kao, J.H., Chen, D.S., Evolution of hepatitis B virus in an acute hepatitis B patient coinfected with genotypes B and C. J GenVirol 87 (2006), 39–49.
49. Liao, H., Li, X., Liu, Y., Xu, Z., Huang, P., Nian, X., et al. Intergenotype recombinant analysis of full-length hepatitis B virus genomes from 516 Chinese patients with different illness categories. J Med Virol 89 (2017), 139–145.
50. Chu, C.M., Liaw, Y.F., Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion. J Viral Hepat 14 (2007), 147–152.
51. Liu, J., Yang, H.I., Lee, M.H., Lu, S.N., Jen, C.L., Batrla-Utermann, R., et al., for the R.E.V.E.A.L.-HBV Study Group. Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma. Gut 63 (2014), 1648–1657.
52. Kao, J.H., Chen, P.J., Lai, M.Y., Chen, D.S., Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection. J Clin Microbiol 40 (2002), 1207–1209.
53. Ni, Y.H., Chang, M.H., Wang, K.J., Hsu, H.Y., Chen, H.L., Kao, J.H., et al. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology 127 (2004), 1733–1738.
54. Kao, J.H., Chen, P.J., Lai, M.Y., Chen, D.S., Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers. J Med Virol 72 (2004), 363–369.
55. Tseng, T.C., Liu, C.J., Chen, C.L., Yang, W.T., Yang, H.C., Su, T.H., et al. Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection. Aliment Pharmacol Ther 41 (2015), 949–960.
56. Sanchez-Tapias, J.M., Costa, J., Mas, A., Bruguera, M., Rodés, J., Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients. Gastroenterology 123 (2002), 1848–1856.
57. Shimakawa, Y., Lemoine, M., Njai, H.F., Bottomley, C., Ndow, G., Goldin, R.D., et al. Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from the Gambia. Gut 65 (2016), 2007–2016.
58. Cheng, H.R., Kao, J.H., Wu, H.L., Chen, T.C., Tseng, T.C., Liu, C.H., et al. Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously. Liver Int 34 (2014), e71–9.
59. Yu, M.W., Yeh, S.H., Chen, P.J., Liaw, Y.F., Lin, C.L., Liu, C.J., et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst 97 (2005), 265–272.
60. Wu, J.C., Huang, Y.H., Chau, G.Y., Su, C.W., Lai, C.R., Lee, P.C., et al. Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma. J Hepatol 51 (2009), 890–897.
61. Yang, H.I., Yeh, S.H., Chen, P.J., Iloeje, U.H., Jen, C.L., Su, J., et al., REVEAL-HBV Study Group. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 100 (2008), 1134–1143.
62. Tseng, T.C., Liu, C.J., Yang, H.C., Su, T.H., Wang, C.C., Chen, C.L., et al. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology 142 (2012), 1140–1149.
63. Yin, J., Zhang, H., Li, C., Gao, C., He, Y., Zhai, Y., et al. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area. Carcinogenesis 29 (2008), 1685–1691.
64. Yan, H., Yang, Y., Zhang, L., Tang, G., Wang, Y., Xue, G., et al. Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma. Hepatology 61 (2015), 1821–1831.
65. Chan, H.L., Tse, C.H., Mo, F., Koh, J., Wong, V.W., Wong, G.L., et al. High viral load and hepatitis B virus subgenotype Ce are associated with increased risk of hepatocellular carcinoma. J Clin Oncol 26 (2008), 177–182.
66. Littlejohn, M., Davies, J., Yuen, L., Edwards, R., Sozzi, T., Jackson, K., et al. Molecular virology of hepatitis B virus, sub-genotype C4 in northern Australian Indigenous populations. J Med Virol 86 (2014), 695–706.
67. Tran, H., Yu, M.L., Dai, C.Y., Lin, I.L., Yeh, M.L., Chuang, W.L., et al. Novel quasi-subgenotype D2 of hepatitis B virus identified in Taiwanese aborigines. Virus Genes 49 (2014), 30–37.
68. Thakur, V., Guptan, R.C., Kazim, S.N., Malhotra, V., Sarin, S.K., Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. J Gastroenterol Hepatol 17 (2002), 165–170.
69. Livingston, S.E., Simonetti, J., McMahon, B., Bulkow, L.R., Hurlburt, K.J., Homan, C.E., et al. Hepatitis B virus genotypes in Alaska native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis 195 (2007), 5–11.
70. Gounder, P.P., Bulkow, L.R., Snowball, M., Negus, S., Spradling, P.R., McMahon, B.J., Hepatocellular carcinoma risk in Alaska native children and young adults with hepatitis B virus: retrospective cohort analysis. J Pediatr 178 (2016), 206–213.
71. Panduro, A., Maldonado-Gonzalez, M., Fierro, N.A., Roman, S., Distribution of HBV genotypes F and H in Mexico and Central America. Antivir Ther 18 (2013), 475–484.
72. Roman, S., Panduro, A., Aguilar-Gutierrez, Y., Maldonado, M., Vazquez-Vandyck, M., Martinez-Lopez, E., et al. A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: a systematic review. Hepatol Int 3 (2009), 343–355.
73. Yeh, C.T., Shen, C.H., Tai, D.I., Chu, C.M., Liaw, Y.F., Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma. Oncogene 19 (2000), 5213–5220.
74. Chen, G.G., Li, M.Y., Ho, R.L., Chak, E.C., Lau, W.Y., Lai, P.B., Identification of hepatitis B X gene mutation in Hong Kong patients with hepatocellular carcinoma. J Clin Virol 34 (2005), 7–12.
75. Guo, X., Jin, Y., Qian, G., Tu, H., Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China. J Hepatol 49 (2008), 718–725.
76. Ma, N.F., Lau, S.H., Hu, L., Xie, D., Wu, J., Yang, J., et al. COOH terminal truncated HBV X protein plays key role in hepatocarcinogenesis. Clin Cancer Res 14 (2008), 5061–5068.
77. Lee, S.A., Mun, H.S., Kim, H., Lee, H.K., Kim, B.J., Hwang, E.S., et al. Naturally occurring hepatitis B virus X deletions and insertions among Korean chronic patients. J Med Virol 83 (2011), 65–70.
78. Kim, H., Lee, S.A., Kim, B.J., X region mutations of hepatitis B virus related to clinical severity. World J Gastroenterol 22 (2016), 5467–5478.
79. Iavarone, M., Trabut, J.B., Delpuech, O., Carnot, F., Colombo, M., Kremsdorf, D., et al. Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection. J Hepatol 39 (2003), 253–261.
80. Wang, Y., Lau, S.H., Sham, J.S.T., Wu, M.C., Wang, T., Guan, X.Y., Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated X gene and hepatocellular carcinogenesis. Oncogene 23 (2004), 142–148.
81. Lin, C.L., Liao, L.Y., Wang, C.S., Chen, P.J., Lai, M.Y., Chen, D.S., et al. Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B. Liver Int 25 (2005), 564–570.
82. Liu, C.J., Chen, B.F., Chen, P.J., Lai, M.Y., Huang, W.L., Kao, J.H., et al. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers. J Infect Dis 193 (2006), 1258–1265.
83. Liu, C.J., Chen, B.F., Chen, P.J., Lai, M.Y., Huang, W.L., Kao, J.H., et al. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study. J Infect Dis 194 (2006), 594–599.
84. Chen, B.F., Liu, C.J., Jow, G.M., Chen, P.J., Kao, J.H., Chen, D.S., High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130 (2006), 1153–1168.
85. Liu, S., Zhang, H., Gu, C., Yin, J., He, Y., Xie, J., et al. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst 101 (2009), 1066–1082.
86. Tseng, T.C., Liu, C.J., Yang, H.C., Chen, C.L., Yang, W.T., Tsai, C.S., et al. Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers. Gut 64 (2015), 292–302.
87. Ito, K., Tanaka, Y., Orito, E., Sugiyama, M., Fujiwara, K., Sugauchi, F., et al. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection. Clin Infect Dis 42 (2006), 1–7.
88. Yuen, M.F., Tanaka, Y., Shinkai, N., Poon, R.T., But, D.Y., Fong, D.Y., et al. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels. Gut 57 (2008), 98–102.
89. Chen, C.H., Changchien, C.S., Lee, C.M., Hung, C.H., Hu, T.H., Wang, J.H., et al. Combined mutations in pres/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case–control study. J Infect Dis 198 (2008), 1634–1642.
90. Tanaka, Y., Mukaide, M., Orito, E., Yuen, M.F., Ito, K., Kurbanov, F., et al. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol 45 (2006), 646–653.
91. Chou, Y.C., Yu, M.W., Wu, C.F., Yang, S.Y., Lin, C.L., Liu, C.J., et al. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma. Gut 57 (2008), 91–97.
92. Kim, J.K., Chang, H.Y., Lee, J.M., Baatarkhuu, O., Yoon, Y.J., Park, J.Y., et al. Specific mutations in the enhancer II/ core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma. J Med Virol 81 (2009), 1002–1008.
93. Jang, J.W., Chun, J.Y., Park, Y.M., Shin, S.K., Yoo, W., Kim, S.O., et al. Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma. Cancer Sci 103 (2012), 296–304.
94. Hu, F., Bi, S., Yan, H., Shi, Y., Sheng, J., Associations between hepatitis B virus basal core promoter/pre-core region mutations and the risk of acute-on-chronic liver failure: a meta-analysis. Virol J, 12, 2015, 87.
95. Nian, X., Xu, Z., Liu, Y., Chen, J., Li, X., Xu, D., Association between hepatitis B virus basal core promoter/precore region mutations and the risk of hepatitis B-related acute-on-chronic liver failure in the Chinese population: an updated meta-analysis. Hepatol Int 10 (2016), 606–615.
96. Lin, C.L., Liu, C.H., Chen, W., Huang, W.L., Chen, P.J., Lai, M.Y., et al. Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma. J Gastroenterol Hepatol 22 (2007), 1098–1103.
97. Fang, Z.L., Sabin, C.A., Dong, B.Q., Wei, S.C., Chen, Q.Y., Fang, K.X., et al. Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study. J Gen Virol 89 (2008), 2882–2890.
98. Liu, S., Xie, J., Yin, J., Zhang, H., Zhang, Q., Pu, R., et al. A matched case-control study of hepatitis B virus mutations in the preS and core promoter regions associated independently with hepatocellular carcinoma. J Med Virol 83 (2011), 45–53.
99. Hsieh, Y.H., Su, I.J., Wang, H.C., Chang, W.W., Lei, H.Y., Lai, M.D., et al. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25 (2004), 2023–2032.
100. Hsieh, Y.H., Chang, Y.Y., Su, I.J., Yen, C.J., Liu, Y.R., Liu, R.J., et al. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis. J Pathol 236 (2015), 337–347.
101. Su, I.J., Wang, L.H., Hsieh, W.C., Wu, H.C., Teng, C.F., Tsai, H.W., et al. The emerging role of hepatitis B virus pre-S2 deletion mutant proteins in HBV tumorigenesis. J Biomed Sci, 21, 2014, 98.